Peripheral vascular disease (PVD) is a common condition that has the potential to cause loss of limb or even loss of life. Peripheral arterial disease (PAD) can manifest as insufficient tissue ...

Glucose level 200 mg/dL (11.1 mmol/L) or greater (or a prior history of diabetes) Beta-hydroxybutyrate concentration 31.23 mg/dL (3.0 mmol/L) or more Mild - Beta-hydroxybutyrate 31.2-62.5 mg/dL, pH ...

Generalized anxiety disorder (GAD) is characterized by excessive and persistent anxiety and worry about multiple events or activities that is difficult to control. The anxiety and worry occur more ...

Patients should be monitored for symptom response, functional improvement, adverse effects of treatment, and changes in suicide risk or psychiatric comorbidity. Inadequate response should prompt ...

The differential diagnosis of acute lymphadenopathy is broad. A patient's medical history and review of systems is important in narrowing this differential. Assess the size, location, and character of ...

Approved for GAD but its short half-life can cause between-dosing spikes in rebound anxiety that can increase the overall potential for misuse compared to other long-acting agents such as Klonopin, a ...

Colonic polyps are slow-growing overgrowths of the colonic mucosa that carry a small risk (< 1%) of becoming malignant. However, because colonic polyps are highly prevalent in the general population ...

The following organizations have released guidelines for the management of generalized anxiety disorder (GAD). Key diagnostic and treatment recommendations have been reviewed and integrated throughout ...

An acrochordon (commonly known as a skin tag and sometimes as a fibroepithelial polyp [FEP]) is a small, soft, common, benign, usually pedunculated neoplasm that is found particularly in persons who ...

The following organizations have released guidelines for the management of psychogenic nonepileptic seizures (PNES). Key diagnostic and treatment recommendations have been reviewed and integrated ...

Grade A (ie, strongly supported) treatment recommendations included the following. Immunocompetent patients - Topical azoles once or twice daily for 2-4 weeks; selenium sulfide once daily for 3 days, ...

American Urology Association (AUA) guidelines for diagnosis and management of genitourinary injuries were amended in 2017 and 2020 to reflect literature that was released since the original ...